
Breakthrough prostate cancer blood test could make NHS screening programme viable
Real-world study demonstrates next-gen EpiSwitch PSE blood test safely reduces unnecessary biopsies by up to 79% while accurately detecting prostate cancer. A real-world study published high-impact journal Cancers demonstrates the transformative potential …